EyePoint Pharmaceuticals shares lost nearly 80% of their value following the disappointing Phase 3 LUCIA trial results for DURAVYU in wet age-related macular degeneration. Levi & Korsinsky is investigating potential securities law violations on behalf of EYPT shareholders who lost money.
NEW YORK , Oct. 19, 2026 /PRNewswire/ -- EyePoint Pharmaceuticals (NASDAQ: EYPT) saw nearly 80% of its market value erased after the market opened following the Company's disclosure that DURAVYU missed the prespecified primary endpoint in the Phase 3 LUCIA trial for wet age-related macular degeneration. If you held EYPT when the LUCIA result reached the market, you may have legal rights. Investors who suffered losses are encouraged to submit your EYPT loss information now . You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com  or by telephone at (212) 363-7500.
×
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56C`QmkAmk:>8 DC4lQ9EEADi^^>>I]AC?6HDH:C6]4@>^>65:2^|$ed_fd`^{6G:\2?5\z@CD:?D<J\{@8@];A8n:5l~pb_afcacQ E:E=6lQ{6G: U2>Aj z@CD:?D<J[ {{!Q 2=ElQ{6G: U2>Aj z@CD:?D<J[ {{!Q ^mk^Amk^5:Gm
kAm%96 {&rxp !92D6 b EC:2=VD AC:>2CJ 6?5A@:?E H2D DE2E:DE:42= ?@?\:?76C:@C:EJ :? >62? 492?86 :? 36DE 4@CC64E65 G:DF2= 24F:EJ Wqr'pX G6CDFD @?\=236= a >8 27=:36C46AE 4@?EC@=] s&#p'*& 72:=65 E@ >66E E9:D 6?5A@:?E[ 56DA:E6 249:6G:?8 <6J D64@?52CJ 6?5A@:?ED[ :?4=F5:?8 2 bgT C65F4E:@? :? EC62E>6?E 3FC56?]k^Am
kAmt*!% D92C69@=56CD H9@ =@DE >@?6J @? {&rxp 2C6 6?4@FC2865 E@ k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcg_`b`f\`U2>Aj9la`aefh_hh_U2>AjFl9EEADTbpTauTauK=<]4@>Tau:?G6DE:82E:@?DTau6JAE\:?G6DE:82E:@?\DF3>:DD:@?\7@C>TbuAC:5Tbsa`bbdhTaeH:C6TbscU2>Aj2lC6BF6DEZ2Z?@\4@DEZC6G:6HZ@7ZJ@FCZt*!%Z=@DD6DQ E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmC6BF6DE 2 ?@\4@DE C6G:6H @7 J@FC t*!% =@DD6Dk^2m @C 42== Wa`aX beb\fd__]k^Am
kAmkDEC@?8mpq~&% %wt ux#|k^DEC@?8m \\ u@C @G6C EH@ 564256D[ {6G: U2>Aj z@CD:?D<J 92D C6AC6D6?E65 D92C69@=56CD :? D64FC:E:6D 4=2DD 24E:@?D] #2?<65 :? x$$ %@A d_ 7@C D6G6? 4@?D64FE:G6 J62CD]k^Am
kAmkDEC@?8muC6BF6?E=J pD<65 "F6DE:@?D p3@FE E96 t*!% x?G6DE:82E:@?k^DEC@?8mk^Am
kAmkDEC@?8m"i w@H >F49 5:5 t*!% DE@4< 5C@Ank^DEC@?8mpi $92C6D 76== C@F89=J g_T 27E6C E96 r@>A2?J 5:D4=@D65 E92E :ED !92D6 b {&rxp EC:2= @7 s&#p'*& 5:5 ?@E >66E :ED AC:>2CJ 6?5A@:?E @7 ?@?\:?76C:@C:EJ E@ @?\=236= 27=:36C46AE] x?G6DE@CD H9@ AFC492D65 D92C6D 2E kDA2?m2==6865=Jk^DA2?m :?7=2E65 AC:46D 2?5 DF776C65 =@DD6D >2J 36 6=:8:3=6 E@ D66< 4@>A6?D2E:@?]k^Am
kAmkDEC@?8m"i (96? 5:5 tJ6!@:?E !92C>246FE:42=D kDA2?m2==6865=Jk^DA2?m >:D=625 :?G6DE@CDnk^DEC@?8mpi %96 :?G6DE:82E:@? 4@?46C?D DE2E6>6?ED >256 367@C6 E96 {&rxp 5:D4=@DFC6 E92E kDA2?m2==6865=Jk^DA2?m 42FD65 :?G6DE@CD E@ AFC492D6 D64FC:E:6D 2E :?7=2E65 AC:46D]k^Am
kAmkDEC@?8m"i (9@ :D 6=:8:3=6 E@ A2CE:4:A2E6 :? E96 t*!% :?G6DE:82E:@?nk^DEC@?8mpi x?G6DE@CD H9@ AFC492D65 t*!% DE@4< @C D64FC:E:6D 2?5 DF776C65 7:?2?4:2= =@DD6D >2J 36 6=:8:3=6] t=:8:3:=:EJ :D 32D65 @? AFC492D6 52E6 2?5 5@4F>6?E65 =@DD6D[ ?@E @? H96E96C J@F DE:== 9@=5 E96 D92C6D]k^Am
kAmkDEC@?8m"i (92E 5@ t*!% :?G6DE@CD ?665 E@ 5@ C:89E ?@Hnk^DEC@?8mpi x?G6DE@CD >2J 82E96C 3C@<6C286 C64@C5D D9@H:?8 AFC492D6 52E6D[ D92C6 BF2?E:E:6D[ 2?5 AC:46D A2:5] k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcg_`b`f\`U2>Aj9lbheb_bc`dgU2>AjFl9EEADTbpTauTauK=<]4@>Tau:?G6DE:82E:@?DTau6JAE\:?G6DE:82E:@?\DF3>:DD:@?\7@C>TbuAC:5Tbsa`bbdhTaeH:C6TbscU2>Aj2l$F3>:EZJ@FCZ:?7@C>2E:@?Z7@CZ2Z?@\4@DETarZ?@\@3=:82E:@?Z6G2=F2E:@?Z@7ZJ@FCZA@E6?E:2=ZC64@G6CJQ E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmk6>m$F3>:E J@FC :?7@C>2E:@? 7@C 2 ?@\4@DE[ ?@\@3=:82E:@? 6G2=F2E:@? @7 J@FC A@E6?E:2= C64@G6CJk^6>mk^2m] }@ :>>65:2E6 24E:@? :D C6BF:C65 E@ C6>2:? 6=:8:3=6 E@ A2CE:4:A2E6 :? E96 :?G6DE:82E:@?]k^Am
kAmkDEC@?8m"i (92E 5@4F>6?ED 5@ x ?665 E@ A2CE:4:A2E6nk^DEC@?8mpi qC@<6C286 DE2E6>6?ED @C EC256 4@?7:C>2E:@?D D9@H:?8 AFC492D6 52E6D[ D92C6 BF2?E:E:6D[ AC:46D A2:5[ 2?5 2?J DF3D6BF6?E D2=6 52E6D 2?5 AC:46D]k^Am
kAmkDEC@?8m"i (92E :7 x 2=C625J D@=5 >J t*!% D92C6D \\ 42? x DE:== C64@G6C =@DD6Dnk^DEC@?8mpi *6D] t=:8:3:=:EJ :D 32D65 @? H96? J@F AFC492D65[ ?@E H96E96C J@F DE:== 9@=5 E96 D92C6D] x?G6DE@CD H9@ 3@F89E t*!% 2?5 D@=5 2E 2 =@DD >2J DE:== A2CE:4:A2E6 :? E96 :?G6DE:82E:@?]k^Am
kAmkDEC@?8m"i s@ x ?665 E@ 8@ E@ 4@FCE @C 8:G6 E6DE:>@?Jnk^DEC@?8mpi }@] !2CE:4:A2E:?8 :? E96 :?G6DE:82E:@? 5@6D ?@E C6BF:C6 4@FCE 2AA62C2?46D @C 56A@D:E:@?D] x7 =682= 24E:@? :D =2E6C AFCDF65[ E96 @G6CH96=>:?8 >2;@C:EJ @7 27764E65 :?G6DE@CD ?6G6C 2AA62C :? 4@FCE 6:E96C]k^Am
kAmkDEC@?8m"i (92E 5@6D :E 4@DE >6 E@ A2CE:4:A2E6nk^DEC@?8mpi %96C6 :D ?@ FA7C@?E 4@DE E@ DF3>:E J@FC :?7@C>2E:@? 2?5 C6G:6H H96E96C J@F >2J 36 6=:8:3=6 E@ C64@G6C] $9@F=5 J@F 49@@D6 E@ A2CE:4:A2E6 :? 2?J C6DF=E:?8 24E:@?[ E96D6 >2EE6CD 2C6 86?6C2==J 92?5=65 @? 2 4@?E:?86?4J 32D:D[ H:E9 2?J 2EE@C?6JDV 766D 2?5 6IA6?D6D DF3;64E E@ 4@FCE 2AAC@G2=]k^Am
kAmr~}%pr%ik^Am
kAm{6G: U2>Aj z@CD:?D<J[ {{!k^Am
kAmy@D6A9 t] {6G:[ tDB]k^Am
kAmt5 z@CD:?D<J[ tDB]k^Am
kAmbb (9:E692== $EC66E[ afE9 u=@@Ck^Am
kAm}6H *@C<[ }* `___ck^Am
kAmk2 9C67lQ>2:=E@i;=6G:o=6G:<@CD:?D<J]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQm;=6G:o=6G:<@CD:?D<J]4@>k^2mk^Am
kAm%6=i Wa`aX beb\fd__k^Am
kAmu2Ii Wa`aX beb\f`f`k^Am
kAmpEE@C?6J p5G6CE:D:?8] !C:@C C6DF=ED 5@ ?@E 8F2C2?E66 D:>:=2C @FE4@>6D]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?l}*fdffdU2>AjD5la_ae\`_\`hQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^6J6A@:?E\A92C>246FE:42=D\:?G6DE:82E:@?\?@E:46\=6G:\\<@CD:?D<J\?@E:7:6D\:?G6DE@CD\@7\A6?5:?8\:?G6DE:82E:@?\:?E@\6J6A@:?E\A92C>246FE:42=D\6JAE\b_ah`b_fg]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^6J6A@:?E\A92C>246FE:42=D\:?G6DE:82E:@?\?@E:46\=6G:\\<@CD:?D<J\?@E:7:6D\:?G6DE@CD\@7\A6?5:?8\:?G6DE:82E:@?\:?E@\6J6A@:?E\A92C>246FE:42=D\6JAE\b_ah`b_fg]9E>=k^2mk^Am
kAm$~&#rt {6G: U2>Aj z@CD:?D<J[ {{!k^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5l}*fdffdU2>Aj%C2?D>:DD:@?0x5la_ae`_`h`fdg!#0}t($0&$!#00000}*fdffdU2>Ajs2E6x5la_ae`_`hQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.